Почетна › Леукемија › Пенсилванија
Kliničke studije za Леукемија u državi Пенсилванија
16 studija za Леукемија traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
Zvanični tekst studije (na engleskom)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Pennsylvania, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникОпсервациона студија
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Penn State Children's Hospital, Hershey
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- и још 1
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 20. 10. 2026. · NCT00736749A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- University of Pennsylvania, Philadelphia
Тражи се учесникФаза 1/2
30 Days · Оба пола · Ажурирано 9. 10. 2026. · NCT04065399Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Pittsburgh
Тражи се учесникФаза 3
Узраст од 18 до 18 · Оба пола · Ажурирано 6. 10. 2026. · NCT07509151Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Spoknwrd Clinical Trials Inc., Easton
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06824168First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07586618Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникФаза 2
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Тражи се учесникОпсервациона студија
Узраст 60 и старији · Оба пола · Ажурирано 12. 8. 2026. · NCT03680677CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникФаза 1
Узраст од 0 до 29 · Оба пола · Ажурирано 7. 7. 2026. · NCT07464951A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 2, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 17. 6. 2026. · NCT05475925Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Saint Christopher's Hospital for Children, Philadelphia
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникФаза 1/2
1 Month – 25 Years · Оба пола · Ажурирано 15. 4. 2026. · NCT06839456A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Hospital of the University of Pennsylvania, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникРана фаза 1
До 30 година · Оба пола · Ажурирано 20. 2. 2026. · NCT02356653SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.